Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT001 for Lateral Canthal Lines
NCT00907387Phase 2Completed
- Sponsor
- Revance Therapeutics
- Start
- Apr 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RT001 in lateral canthal rhytides, sponsored by Revance Therapeutics. Started Apr 2009; status: completed.
02
Drugs
RT001
03
Conditions
lateral canthal rhytides
Beyond the preview
Go deeper on NCT00907387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907387.